GODAVARI

GODAVARI DRUGS

Small Cap BSE: 530317 NSE: GODAVARI
₹67.25
1.4 (2.13%)
As on 19 August, 2022 | 08:00

Godavari Drugs Share Price

Godavari Drugs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Godavari Drugs Share Returns

  • Over 1 Month 11.06%
  • Over 3 Month -3.24%
  • Over 6 Month 10.69%
  • Over 1 Year -5.94%

Godavari Drugs Key Statistics

Godavari Drugs Investment Rating

  • Master Rating:
  • Godavari Drugs has an operating revenue of Rs. 159.25 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 17% is exceptional. The company has a reasonable debt to equity of 40%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 6% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 48 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 105 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Godavari Drugs Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 43
  • 44
  • 34
  • 39
  • 44
  • 33
  • Operating Expenses Qtr Cr
  • 40
  • 42
  • 31
  • 36
  • 41
  • 30
  • Operating Profit Qtr Cr
  • 2
  • 3
  • 3
  • 3
  • 3
  • 3
  • Depreciation Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Interest Qtr Cr
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tax Qtr Cr
  • 0
  • 1
  • 0
  • 1
  • 1
  • 0
  • Net Profit Qtr Cr
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

Godavari Drugs Technicals

EMA & SMA

Current Price
67.3
1.45 (2.2%)
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • 66.36
  • 50 Day
  • 65.86
  • 100 Day
  • 65.49
  • 200 Day
  • 63.84
  • 20 Day
  • 67.41
  • 50 Day
  • 64.62
  • 100 Day
  • 67.08
  • 200 Day
  • 63.81

Godavari Drugs Resistance and Support

PIVOT
₹65.39
Resistance
  • First Resistance
  • 67.32
  • Second Resistance
  • 68.79
  • Third Resistance
  • 70.72
Support
  • First Resistance
  • 63.92
  • Second Resistance
  • 61.99
  • Third Resistance
  • 60.52
  • RSI
  • 53.24
  • MFI
  • 44.95
  • MACD Single Line
  • 0.66
  • MACD
  • 0.29

Godavari Drugs Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 3,009
  • 293,708
  • 97.61
  • Week
  • 8,589
  • 666,010
  • 77.54
  • 1 Month
  • 5,426
  • 435,302
  • 80.22
  • 6 Month
  • 11,156
  • 902,185
  • 80.87

Godavari Drugs Result Highlights

Godavari Drugs Synopsis

BSE-Medical-Generic Drugs

Godavari Drugs is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 161.11 Cr. and Equity Capital is Rs. 7.53 Cr. for the Year ended 31/03/2022. Godavari Drugs Ltd. is a Public Limited Listed company incorporated on 02/12/1987 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230TG1987PLC008016 and registration number is 008016.
  • Market Cap
  • 51
  • Sales
  • 159
  • Shares in Float
  • 0.32
  • No of funds
  • 4
  • Yield
  • Book Value
  • 1.71
  • U/D Vol ratio
  • 0.9
  • LTDebt / Equity
  • 40
  • Alpha
  • Beta
  • 0.66

Godavari Drugs

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 56.92%
  • 56.36%
  • 56.13%
  • Financial Institutions/ Banks
  • 0.5%
  • 0.5%
  • 0.5%
  • Individual Investors
  • 35.87%
  • 35.58%
  • 36.14%
  • Others
  • 6.71%
  • 7.56%
  • 7.23%

Godavari Drugs Management

  • Name
  • Designation
  • Mr. Ghanshyam Jaju
  • Chairman
  • Mr. Mukund Kakani
  • Managing Director
  • Mr. Mohit Jaju
  • Executive Director
  • Mr. Kirti Kumar Jain
  • CFO & Wholetime Director
  • Mr. Dilip Keshavlal Patel
  • Non Exe. & Ind. Director
  • Mr. Syed Anis Hussain
  • Non Exe. & Ind. Director
  • Mr. Ramesh Babu Telugu
  • Non Exe. & Ind. Director
  • Mrs. Vimala Madon
  • Non Exe. & Ind. Director

Godavari Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Godavari Drugs Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-13
  • Quarterly Results
  • 2022-04-19
  • Audited Results
  • 2022-02-14
  • Quarterly Results
  • 2021-11-12
  • Quarterly Results
  • 2021-08-14
  • Quarterly Results

Godavari Drugs FAQs

What is Share Price of Godavari Drugs ?

Godavari Drugs share price is ₹67 As on 19 August, 2022 | 07:46

What is the Market Cap of Godavari Drugs ?

The Market Cap of Godavari Drugs is ₹50.6 Cr As on 19 August, 2022 | 07:46

What is the P/E ratio of Godavari Drugs ?

The P/E ratio of Godavari Drugs is 10.7 As on 19 August, 2022 | 07:46

What is the PB ratio of Godavari Drugs ?

The PB ratio of Godavari Drugs is 1.7 As on 19 August, 2022 | 07:46

Q1FY23